Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $10.85 USD
Change Today -0.24 / -2.16%
Volume 223.7K
As of 8:10 PM 06/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kim D. Blickenstaff

Chief Executive Officer, President and Director, Tandem Diabetes Care, Inc.
AgeTotal Calculated CompensationThis person is connected to 52 board members in 6 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Kim D. Blickenstaff has been the President and Chief Executive Officer of Tandem Diabetes Care, Inc. since September 2007. Mr. Blickenstaff has more than 30 years of healthcare experience in finance, marketing management, sales and strategic planning. He has an extensive medical device and diagnostics experience. He is the Co-founder of Biosite Inc. and served as its Chief Executive Officer and Treasurer. He served as the President of Biosite Inc., from April 1988 ...

Read Full Background

Corporate Headquarters*

11045 Roselle Street
San Diego, California 92121

United States

Phone: 858-366-6900
Fax: --

Board Members Memberships*

Co-Founder, Chairman, Chief Executive Officer, Treasurer, and Member of Stock Option Committee
Former Director and Member of Audit Committee
Independent Director and Member of Compensation Committee
Chairman and Member of Audit Committee
Chief Executive Officer, President and Director
Former Director


Graduate School of Business, Loyola University
Loyola Marymount University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$532,692

Stock Options*

All Other Compensation$2,774
Exercisable Options627,620
Unexercisable Options496,098
Total Number of Options1,123,718

Total Compensation*

Total Annual Cash Compensation$789,646
Total Short Term Compensation$532,692
Other Long Term Compensation$2,774
Total Calculated Compensation$789,646
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TNDM:US $10.85 USD -0.24


Vincent A. Forlenza BDChairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
Kevin R. Sayer Chief Executive Officer, President and Director
DexCom, Inc.
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
Patrick J. Sullivan Chief Executive Officer, President and Director
Insulet Corporation
Philip Bowman Chief Executive Officer and Executive Director
Smiths Group plc
1.5M GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TANDEM DIABETES CARE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at